Abstract
The processes by which ErbB-3, an inactive tyrosine kinase, exerts its biological effects are poorly understood. Using the yeast two-hybrid system, we have isolated an ErbB-3 binding protein (Ebp1) that interacts with the juxtamembrane domain of ErbB-3. This protein is identical to that predicted to be encoded for by the human PA2G4 gene. Ebp1 is the human homologue of a previously identified cell cycle-regulated mouse protein p38-2G4. Two transcripts of ebp1 mRNA (1.7 and 2.2 kb) were detected in several normal human organs. The interaction of Ebp1 with ErbB-3 was examined in vitro and in vivo. The first 15 amino acids of the juxtamembrane domain of ErbB-3 were essential for Ebp1 binding in vitro. Treatment of AU565 cells with the ErbB-3 ligand heregulin resulted in dissociation of Ebp1 from ErbB-3. Ebp1 translocated from the cytoplasm into the nucleus following heregulin stimulation. These findings suggest that Ebp1 may be a downstream member of an ErbB-3-regulated signal transduction pathway. © 2000 Cancer Research Campaign
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Bacus SS, Gudkov AV, Zelnick CR, Chin D, Stern R, Stancovski I, Peles E, Ben-Baruch N, Farbstein H, Lupu R, Wen D, Sela M and Yarden Y (1993) Neu Differentiation Factor (heregulin) induces expression of intercellular adhesion molecule 1: implications for mammary tumour. Cancer Res 53: 5251–5261
Bargmann CI, Hung M-C and Weinberg RA (1986) The neu oncogene encodes an epidermal growth factor receptor-related protein. Nature 319: 226–230
Carraway KLIII, Sliwkowski MX, Akita R, Platko JV, Guy PM, Nuijens A, Diamonti AJ, Vandlen RL, Cantley LC and Cerione RA (1994) The erbB3 gene product is a receptor for heregulin. J Biol Chem 269: 14303–14306
Carraway KLIII, Soltoff SP, Diamonti AJ and Cantley LC (1995) Heregulin stimulates mitogenesis and phosphatidylinositol 3-kinase in mouse fibroblasts transfected with erbB2/neu and erbB3. J Biol Chem 270: 7111–7116
Castagnino P, Biesova Z, Wong WT, Fazioli F, Gill GN and Di Fiore PP (1995) Direct binding of eps8 to the juxtamembrane domain of EGFR is phosphotyrosine- and SH2-independent. Oncogene 10: 723–729
Fazioli F, Minichiello L, Matoska V, Castagnino P, Miki T, Wong WT and Di Fiore PP (1993) Eps8, a substrate for the epidermal growth factor receptor kinase, enhances EGF-dependent mitogenic signals. EMBO J 12: 3799–3808
Fedi P, Pierce JH, DiFiore PP and Kraus MH (1994) Efficient coupling with phosphatidylinositol 3-kinase, but not phospholipase C γ or GTPase activating protein, distinguished erbB-3 signaling from that of other ErbB/EGFR family members. Mol Cell Biol 14: 492–500
Fields S and Song O (1989) A novel genetic system to detect protein–protein interactions. Nature 340: 245–246
Galcheva-Gargova Z, Konstantinov KN, Wu I-H, Klier FG, Barrett T and Davis RJ (1996) Binding of zinc protein ZPR1 to the epidermal growth factor receptor. Science 272: 1795–1797
Gamett DC, Greene T, Wagreich AR, Kim HH, Koland JG and Cerione RA (1995) Heregulin-stimulated signaling in rat pheochromocytoma cells. J Biol Chem 270: 19022–19027
Goldman R, Ben-Levy R, Peles E and Yarden Y (1990) Heterodimerization of the erbB1 and erbB2 receptors in human breast carcinoma cells: a mechanism for receptor transregulation. Biochemistry 29: 11024–11028
Gullick WJ (1991) Prevalence of aberrant expression of the epidermal growth factor receptor in human cancers. Br Med Bull 47: 87–98
Guy PM, Platko JV, Cantley LC, Cerione RA and Carraway KLIII (1994) Insect cell-expressed p180erbB3possesses an impaired tyrosine kinase activity. Proc Natl Acad Sci USA 91: 8132–8136
Hellyer NJ, Kim HH, Greaves CH, Sierke SL and Koland JG (1995) Cloning of the rat erbB3 cDNA and characterization of the recombinant protein. Gene 165: 279–284
Holmes WE, Sliwkowski MX, Akita RW, Henzel WJ, Lee J, Park JW, Yansura D, Abadi N, Raab H, Lewis GD, Shepard HM, Kuang W-J, Wood WI, Goeddel DV and Vandlen RL (1992) Identification of heregulin, a specific activator of p185erbB2. Science 256: 1205–1210
Jarriault S, Brou C, Logeat F, Schroeter EH, Kopan R and Israel A (1995) Signaling downstream of activated mammalian Notch. Nature 377: 355–358
Jo SA, Zhu X, Marchionni MA and Burden SJ (1995) Neuregulins are concentrated at nerve–muscle synapses and activate Ach-receptor gene expression. Nature 373: 158–161
Kim HH, Sierke SL and Koland JG (1994) Epidermal growth factor-dependent association of phosphatidylinositol-3 kinase with the erbB-3 gene product. J Biol Chem 269: 24747–24755
Kraus MH, Issing W, Miki T, Popescu NC and Aaronson SA (1989) Isolation and characterization of ERBB3, a third member of the ERBB/ epidermal growth factor receptor family: evidence for overexpression in a subset of human mammary tumors. Proc Natl Acad Sci USA 86: 9193–9197
Lamartine J, Seri M, Cinti R, Heitzmann F, Creaven M, Radomski N, Jost E, Lenoir GM, Romeo G and Sylla BS (1997) Molecular cloning and mapping of a human cDNA (PA2G4) that encodes a protein highly homologous to the mouse cell cycle protein p38-2G4. Cytogenet Cell Genet 78: 31–35
Lemoin NR, Barnes DM, Hollywood DP, Hughes CM, Smith P, Dublin E, Prigent SA, Gullick WJ and Hurst HC (1992) Expression of ERBB3 gene product in breast cancer. Br J Cancer 66: 1116–1121
Macias-Silva M, Abdollah S, Hoodless PA, Pirone R, Attisano L and Wrana JL (1995) MADR2 is a substrate of the TGFβ receptor and its phosphorylation is required for nuclear accumulation and signaling. Cell 87: 1215–1224
Marte BM, Jeschke M, Graus-Porta D, Taverna D, Hofer P, Groner B, Yarden Y and Hynes NE (1995) Neu differentiation factor/heregulin modulates growth and differentiation of HC11 mammary epithelial cells. Mol Endocrinol 9: 14–23
Noguchi M, Mura M, Bennett B, Lupu R, Hui F, Harris CC and Gerwin BI (1993) Biological consequences of overexpression of a transfected c-erbB-2 gene in immortalized human bronchial epithelial cells. Cancer Res 53: 2035–2043
Olayioye MA, Graus-Porta D, Berrli RR, Rohrer J, Gay B and Hynes NE (1998) ErbB-1 and ErbB-2 acquire distinct signaling properties dependent upon their dimerization partner. Mol Cell Biol 18: 5042–5051
Peles E, Bacus SS, Koski RA, Lu HS, Wen D, Ogden SG, Levy RB and Yarden Y (1992) Isolation of the Neu/HER-2 stimulatory ligand: a 44 kDa glycoprotein that induces differentiation of mammary tumor cells. Cell 69: 205–216
Pierce JH, Arnstein P, DiMarco E, Antrip J, Kraus MH, Lonardo F, DiFiore PP and Aaronson SA (1991) Oncogenic potential of erbB-2 in human mammary epithelial cells. Oncogene 6: 1189–1194
Plowman GD, Whitney GS, Neubauer MG, Green JM, McDonald VL, Todaro GJ and Shoyab M (1990) Molecular cloning and expression of an additional epidermal growth factor receptor-related gene. Proc Natl Acad Sci USA 87: 4905–4909
Radomski N and Jost E (1995) Molecular cloning of a murine cDNA encoding a novel protein, p38-2G4, which varies with the cell cycle. Exp Cell Res 220: 434–445
Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE, Levin WJ, Stuart SG, Udove J, Ullrich A and Press MF (1989) Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 244: 707–712
Sliwkowski MX, Schaefer G, Akita RW, Lofgren JA, Fitzpatrik VD, Nuijens A, Fendly BM, Cerione RA, Vandlen RL and Carraway KLIII (1994) Coexpression of erbB2 and erbB3 proteins reconstitutes a high affinity receptor for heregulin. J Biol Chem 269: 14661–14665
Soltoff SP, KLIII, Prigent SA, Gullick WG and Cantley LC (1994) ErbB3 is involved in activation of phosphatidylinositol-3 kinase by epidermal growth factor. Mol Cell Biol 14: 3550–3558
Ullrich A, Coussens L, Hayflick JS, Dull TJ, Gray A, Tam AW, Lee J, Yarden Y, Libermann TA, Schlessinger J, Downward J, Mayes ELV, Whittle N, Waterfield MD and Seeburg PH (1984) Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells. Nature 309: 418–425
Yamada H, Mori H, Momoi H, Nakagawa Y, Ueguchi C and Mizuno T (1994) A fission yeast gene encoding a protein that preferentially associates with curved DNA. Yeast 10: 883–894
Yoo J-Y and Hamburger AW (1998) Changes in heregulin β1 (HRGβ1) signaling after inhibition of ErbB-2 expression in a human breast cancer cell line. Mol Cell Endoc 138: 163–171
Yoo J-Y and Hamburger AW (1999) Interaction of the p23/p198 protein with ErbB-3. Gene 229: 215–221
Zhang K, Sun J, Wen D, Chang D, Thomason A and Yoshinaga SK (1996) Transformation of NIH 3T3 cells by HER3 and HER4 receptors requires the presence of HER1 or HER2. J Biol Chem 271: 3884–3890
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Yoo, JY., Wang, X., Rishi, A. et al. Interaction of the PA2G4 (EBP1) protein with ErbB-3 and regulation of this binding by heregulin. Br J Cancer 82, 683–690 (2000). https://doi.org/10.1054/bjoc.1999.0981
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1054/bjoc.1999.0981
Keywords
This article is cited by
-
The roles of multifunctional protein ErbB3 binding protein 1 (EBP1) isoforms from development to disease
Experimental & Molecular Medicine (2020)
-
The expression and prognostic role of EBP1 and relationship with AR in HER2+ breast cancer
Virchows Archiv (2020)
-
The ErbB3-binding protein EBP1 modulates lapatinib sensitivity in prostate cancer cells
Molecular and Cellular Biochemistry (2015)
-
High expression of ErbB3 binding protein 1 (EBP1) predicts poor prognosis of pancreatic ductal adenocarcinoma (PDAC)
Tumor Biology (2015)
-
The downregulation of ErbB3 binding protein 1 (EBP1) is associated with poor prognosis and enhanced cell proliferation in hepatocellular carcinoma
Molecular and Cellular Biochemistry (2014)